Corbus Pharmaceuticals Holdings, Inc. (CRBP)
3.99
+0.06
(+1.53%)
USD |
NASDAQ |
Nov 11, 16:00
3.99
0.00 (0.00%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2021 | -2.24K% |
| June 30, 2021 | -12.55K% |
| March 31, 2021 | -2.48K% |
| December 31, 2020 | -1.31K% |
| September 30, 2020 | -2.84K% |
| June 30, 2020 | -13.31K% |
| March 31, 2020 | -1.68K% |
| December 31, 2019 | -1.03K% |
| September 30, 2019 | -802.8% |
| June 30, 2019 | 7.40% |
| March 31, 2019 | -1.39K% |
| December 31, 2018 | -898.0% |
| September 30, 2018 | -1.34K% |
| Date | Value |
|---|---|
| June 30, 2018 | -1.41K% |
| March 31, 2018 | -1.23K% |
| December 31, 2017 | |
| September 30, 2017 | -874.7% |
| June 30, 2017 | -2.08K% |
| March 31, 2017 | -577.1% |
| December 31, 2016 | -2.01K% |
| September 30, 2016 | -720.0% |
| June 30, 2016 | -1.06K% |
| March 31, 2016 | -729.2% |
| December 31, 2015 | -685.9% |
| September 30, 2015 | -1.32K% |
| June 30, 2015 | -2.26K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | -14.20% |
| Tonix Pharmaceuticals Holding Corp. | -309.4% |
| Karyopharm Therapeutics, Inc. | -200.5% |
| Minerva Neurosciences, Inc. | -- |
| Ocugen, Inc. | -184.4% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -105.2% |
| Return on Assets | -86.53% |
| Return on Invested Capital | -102.7% |
| Return on Net Operating Assets | -3.32K% |